Get the Stockscreener App
0.3396
3.66%
0.012
Mangoceuticals Inc stock is traded at $0.3396, with a volume of 456.42K.
It is up +3.66% in the last 24 hours and down -19.14% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$0.3276
Open:
$0.34
24h Volume:
456.42K
Relative Volume:
0.61
Market Cap:
$7.55M
Revenue:
$414.60K
Net Income/Loss:
$-19.21M
P/E Ratio:
-0.2095
EPS:
-1.6207
Net Cash Flow:
$-4.89M
1W Performance:
-21.46%
1M Performance:
-19.14%
6M Performance:
-15.94%
1Y Performance:
-86.63%
1-Day Range:
$0.33
$0.3624
1-Week Range:
$0.3066
$0.4398
52-Week Range:
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.3396 | 7.55M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
312.67 | 50.62B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
69.31 | 12.58B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.42 | 12.35B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
105.31 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.42 | 7.64B | 1.34B | 230.70M | 440.96M | 2.6695 |
Mangoceuticals Inc Stock (MGRX) Latest News
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com South Africa
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com India
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com Canada
Form 4 Mangoceuticals Inc For: 6 October - Investing.com India
CFO receives 100,000 shares at Mangoceuticals (MGRX), holds 220,000 directly afterward. - Stock Titan
A CEO stock bonus is issuable instead of a change-of-control payment at Mangoceuticals (MGRX). - Stock Titan
With 1.63M option shares included, Mangoceuticals (MGRX) CEO reports his ownership stake. - Stock Titan
For board services, Mangoceuticals (MGRX) director Alex P. Hamilton received 100,000 shares. - Stock Titan
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why - Benzinga
Mangoceuticals Announces $2.5 Million Subsidiary-Level Investment in MangoRx IP Holdings to Advance Antiviral Portfolio Commercialization - Quiver Quantitative
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche - GlobeNewswire Inc.
Investors agreed to buy 25% of Mangoceuticals’ company holding antiviral patents for $2.5 million. - Stock Titan
Mangoceuticals Secures $2.5 Million Strategic Investment in - GlobeNewswire
Mangoceuticals Terminates Planned Business Combination with Nuclea - The Globe and Mail
Mangoceuticals Terminates Planned Business Combination with Nuclea - TipRanks
Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView
Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView
Mangoceuticals Company Profile & Introduction - Moomoo
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesEarnings Yield Analysis - vinanet.vn
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Nigeria
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Canada
Why is Mangoceuticals stock surging today? - Investing.com India
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Why is Mangoceuticals stock surging today? - Investing.com
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - TradingView
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - GlobeNewswire
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - TipRanks
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - Yahoo Finance
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesFactor ETF Flow - vinanet.vn
Mangoceuticals Granted 180-Day Extension by Nasdaq to - GlobeNewswire
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
| JOHNSTON EUGENE M | Officer |
Dec 03 '25 |
Proposed Sale |
1.16 |
128,333 |
148,866 |
0 |
| Hamilton Alex P. | Director |
Nov 19 '25 |
Sale |
1.22 |
125,000 |
152,875 |
3,334 |
| Hamilton Alex P. | Director |
Nov 19 '25 |
Proposed Sale |
1.24 |
125,000 |
155,125 |
0 |
0.72%
3.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):